Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Revenue (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Revenue for 4 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Revenue fell 27.85% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2025, down 34.18% year-over-year, with the annual reading at $6.2 million for FY2025, 34.18% down from the prior year.
  • Revenue for Q4 2025 was $1.6 million at bioAffinity Technologies, up from $1.4 million in the prior quarter.
  • The five-year high for Revenue was $2.4 million in Q1 2024, with the low at $921.0 in Q1 2023.
  • Average Revenue over 4 years is $1.2 million, with a median of $1.4 million recorded in 2025.
  • The sharpest move saw Revenue skyrocketed 261180.24% in 2024, then tumbled 47.05% in 2025.
  • Over 4 years, Revenue stood at $2346.0 in 2022, then skyrocketed by 94245.95% to $2.2 million in 2023, then dropped by 0.26% to $2.2 million in 2024, then dropped by 27.85% to $1.6 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $1.6 million, $1.4 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.